Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Sareum Share News (SAR)
SAR Share
Price
SAR Share
News
SAR Share
Chat22
SAR Share
Trades11
SAR
Live RNS
SAR Share
Charts
SAR Level 2
Console
SAR Live
Share Price
SAR Broker
Ratings
SAR Directors
Deals
SAR Financial
Diary
SAR
Fundamentals
SAR Short
Positions
SAR
Media
SAR Company
Research
SAR Company
Timeline
Share Price Information for Sareum (SAR)
Last checked at -
Last checked at 
Intraday Sareum Share Chart
Sareum News
IN BRIEF: Sareum doses first subjects in psoriasis drug trial
Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune diseases and cancers - Announces successful do...
TRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effect
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Sareum gets approval for phase one psoriasis studies in Australia
(Sharecast News) - Biotechnology developer Sareum Holdings announced on Friday that it has been granted approval by Australia's Therapeutic Goods Admi...
Sareum receives Australian approval for psoriasis drug clinical trial
Alliance News) - Sareum Holdings PLC on Friday said its application to start a phase 1 clinical trial in Australia of its lead product, psoriasis drug...
AIM WINNERS & LOSERS: Aptamer says struggling to convert pipeline
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
Sareum Holdings interim loss widens as touts psoriasis candidate drug
(Alliance News) - Sareum Holdings PLC on Wednesday reported an increased half-year loss for the six months to December 31, as it continued to work on ...
IN BRIEF: Sareum makes trial application for SDC-1801 in Australia
Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune disease and cancer - On Wednesday, says it has...
Follow the stocks
